{"organizations": [], "uuid": "0dfb60efeb52e33242c722123ea4b0e1e03c86cc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-promore-pharma-gets-patent-the-us/brief-promore-pharma-gets-patent-the-us-idUSFWN1PR09O", "country": "US", "domain_rank": 408, "title": "BRIEF-Promore Pharma Gets Patent The US", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.76, "site_type": "news", "published": "2018-02-01T15:40:00.000+02:00", "replies_count": 0, "uuid": "0dfb60efeb52e33242c722123ea4b0e1e03c86cc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-promore-pharma-gets-patent-the-us/brief-promore-pharma-gets-patent-the-us-idUSFWN1PR09O", "ord_in_thread": 0, "title": "BRIEF-Promore Pharma Gets Patent The US", "locations": [], "entities": {"persons": [{"name": "promore", "sentiment": "negative"}], "locations": [{"name": "us", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - PROMORE PHARMA AB:\n* PROMORE PHARMA IS GRANTED A PATENT FOR PXL01 IN THE US Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-01T15:40:00.000+02:00", "crawled": "2018-02-02T13:11:10.020+02:00", "highlightTitle": ""}